KIT and breast cancer: To further analyze off-target toxicity, breast cancer cell lines ZR-75-1, MDA-MB-175VII, not driven by KIT and PDGFRA, and kinase-independent leiomyosarcoma cell line SK-LMS-1 were also investigated (Supplementary Tables 2 and 12).